Peiwen Yu

3.0k total citations · 1 hit paper
22 papers, 1.9k citations indexed

About

Peiwen Yu is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Peiwen Yu has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Biomedical Engineering. Recurrent topics in Peiwen Yu's work include Nanoplatforms for cancer theranostics (4 papers), Cancer Mechanisms and Therapy (3 papers) and Liver physiology and pathology (3 papers). Peiwen Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Cancer Mechanisms and Therapy (3 papers) and Liver physiology and pathology (3 papers). Peiwen Yu collaborates with scholars based in China, United States and Australia. Peiwen Yu's co-authors include F. Michael Yakes, Alison Joly, Frauke Bentzien, Stefan Engst, Jenny Tan, Fawn Qian, Toshihiro Yamaguchi, Yongchang Shi, Belinda Cancilla and Felix Chu and has published in prestigious journals such as Applied and Environmental Microbiology, Cancer Research and Journal of Hazardous Materials.

In The Last Decade

Peiwen Yu

19 papers receiving 1.8k citations

Hit Papers

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, S... 2011 2026 2016 2021 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
    2011 1.0k citations F. Michael Yakes, Jason Chen et al. Molecular Cancer Therapeutics profile →

Peers

Peiwen Yu
Takayuki Kimura Japan
Heike Richly Germany
Lila Adnane United States
Anna Saborowski Germany
Jubo Zhang China
Toshimitsu Uenaka Japan
Kazushige Mori Japan
Laura W. Goff United States
M Imamura Japan
Sachiko Ogasawara Japan
Takayuki Kimura Japan
Peiwen Yu
Citations per year, relative to Peiwen Yu Peiwen Yu (= 1×) peers Takayuki Kimura

Countries citing papers authored by Peiwen Yu

Since Specialization
Citations

This map shows the geographic impact of Peiwen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwen Yu more than expected).

Fields of papers citing papers by Peiwen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiwen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwen Yu. The network helps show where Peiwen Yu may publish in the future.

Co-authorship network of co-authors of Peiwen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Peiwen Yu. A scholar is included among the top collaborators of Peiwen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiwen Yu. Peiwen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaohui, Chen Zhang, Hongping Wang, et al.. (2025). Unveiling the key aroma-active volatiles influencing consumer preferences in typical oriental melon varieties by molecular sensory science methods. Journal of Food Composition and Analysis. 143. 107527–107527. 2 indexed citations
2.
3.
Li, Xiaohui, Chen Zhang, Peiwen Yu, et al.. (2025). Dissipation patterns of trisiloxane ethoxylates in cucumber plants and field soils: Insights from different end-capping groups. Journal of Hazardous Materials. 487. 137167–137167.
4.
Wang, Hongping, et al.. (2025). Distribution, uptake, and daily exposure of per- and polyfluoroalkyl substances in a paddy field: A growth cycle study. Journal of Hazardous Materials. 492. 138256–138256. 5 indexed citations
5.
Ding, Lei, Xiaolong Zhang, Peiwen Yu, et al.. (2023). Genetically engineered nanovesicles mobilize synergistic antitumor immunity by ADAR1 silence and PDL1 blockade. Molecular Therapy. 31(8). 2489–2506. 25 indexed citations
6.
Yu, Peiwen, et al.. (2023). ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY OF AZAADAMANTANES - ANALOGUES OF AMANTADINE. Химия в интересах устойчивого развития. 31(6). 692–697.
7.
Hsu, Jeff, Jeffrey Serrill, Sharon Wu, et al.. (2022). Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER. Molecular Cancer Therapeutics. 22(2). 179–191. 12 indexed citations
8.
Cao, Yanbing, Wei De, Lixia Yang, et al.. (2022). Nanoplatform Self‐Assembly from Small Molecules of Porphyrin Derivatives for NIR‐II Fluorescence Imaging Guided Photothermal‐Immunotherapy. Advanced Healthcare Materials. 11(11). e2102526–e2102526. 39 indexed citations
9.
Yu, Peiwen, Dongye Zheng, Cuilin Zhang, Ming Wu, & Xiaolong Liu. (2021). Protocol to prepare functional cellular nanovesicles with PD1 and TRAIL to boost antitumor response. STAR Protocols. 2(1). 100324–100324. 5 indexed citations
10.
Zheng, Dongye, Peiwen Yu, Zuwu Wei, et al.. (2020). RBC Membrane Camouflaged Semiconducting Polymer Nanoparticles for Near-Infrared Photoacoustic Imaging and Photothermal Therapy. Nano-Micro Letters. 12(1). 94–94. 75 indexed citations
11.
Wu, Ming, Dongye Zheng, Da Zhang, et al.. (2020). Converting Immune Cold into Hot by Biosynthetic Functional Vesicles to Boost Systematic Antitumor Immunity. iScience. 23(7). 101341–101341. 41 indexed citations
12.
Cao, Yanbing, Dongye Zheng, Qin Li, et al.. (2019). Facile phase transfer of hydrophobic Fe3O4@Cu2−xS nanoparticles by red blood cell membrane for MRI and phototherapy in the second near-infrared window. Journal of Materials Chemistry B. 8(6). 1202–1211. 32 indexed citations
13.
Yu, Peiwen, et al.. (2016). Phosphorus Removal from Aqueous Solution by Pre- or Post-Modified Biochars Derived from Agricultural Residues. Water Air & Soil Pollution. 227(10). 34 indexed citations
14.
Bentzien, Frauke, Yongchang Shi, Peiwen Yu, et al.. (2013). In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer. Thyroid. 23(12). 1569–1577. 102 indexed citations
15.
Wong, Harvey, Laurent Vernillet, Amy Peterson, et al.. (2012). Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor. Clinical Cancer Research. 18(11). 3090–3099. 65 indexed citations
16.
Yakes, F. Michael, Jason Chen, Jenny Tan, et al.. (2011). Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth. Molecular Cancer Therapeutics. 10(12). 2298–2308. 1036 indexed citations breakdown →
17.
18.
Qian, Fawn, Stefan Engst, Toshihiro Yamaguchi, et al.. (2009). Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases. Cancer Research. 69(20). 8009–8016. 282 indexed citations
19.
Müller, Thomas, Samuel E. DePrimo, Peiwen Yu, et al.. (2009). Abstract B269: Pharmacodynamic and correlative biomarker analyses in clinical trials of XL184, an oral, potent inhibitor of MET, VEGFR2, and RET. Molecular Cancer Therapeutics. 8(12_Supplement). B269–B269. 4 indexed citations
20.
Chu, Peter C., H. Zhao, Erlina S. Pali, et al.. (2003). Systematic identification of regulatory proteins critical for T-cell activation. Journal of Biology. 2(3). 21–21. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayuki Kimura Breakdown of academic impact, for papers by Heike Richly Breakdown of academic impact, for papers by Lila Adnane Breakdown of academic impact, for papers by Anna Saborowski Breakdown of academic impact, for papers by Jubo Zhang Breakdown of academic impact, for papers by Toshimitsu Uenaka Breakdown of academic impact, for papers by Kazushige Mori Breakdown of academic impact, for papers by Laura W. Goff Breakdown of academic impact, for papers by M Imamura Breakdown of academic impact, for papers by Sachiko Ogasawara
Rankless by CCL
2026